Pharmacare News Bulletins

Nova Scotia Pharmacare

Pharmacare News Bulletins

The Pharmacare News Bulletins, which are mailed to pharmacies and prescribers, are listed below. They are an important source of information as they provide timely information on recent changes to the Pharmacare Programs.

Please continue to refer to the Pharmacare News Bulletins to stay current with Formulary and Pharmacare Program updates.

Pharmacy edition

Latest Issues

March Bulletin Vol 24-05 (PDF)
Paxlovid Availability in Nova Scotia

February Bulletin Vol 24-04 (PDF)
New Exception Status Benefits: Kerendia (finerenone), Saphnelo (anifrolumab), Zeposia (ozanimod); Criteria Update: Brukinsa (zanubrutinib); New Benefits; Temporary Benefit – US-Labelled Glucagon Injection; Pharmacare News Bulletins Online; Updating Pharmacy Licence In CANImmunize; Ozempic Billing Reminder

February Bulletin Vol 24-03 (PDF)
Ozempic and Rybelsus Update

January Bulletin Vol 24-02 (PDF)

January Bulletin Vol 24-01 (PDF)
Cystic Fibrosis Therapies Update

Prescriber edition

Latest Issues

March Bulletin Vol 24-05 (PDF)
Paxlovid Availability in Nova Scotia

February Bulletin Vol 24-04 (PDF)
New Exception Status Benefits: Kerendia (finerenone), Saphnelo (anifrolumab), Zeposia (ozanimod); Criteria Update: Brukinsa (zanubrutinib); New Benefits: Temporary Benefit – US-Labelled Glucagon Injection; Pharmacare News Bulletins Online

February Bulletin Vol 24-03 (PDF)
Criteria Update: Ozempic (semaglutide), New Exception Status Benefit, Rybelsus (semaglutide)

January Bulletin Vol 24-02 (PDF)

January Bulletin Vol 24-01 (PDF)
Cystic Fibrosis Therapies Update